Metabolic energy sensors as targets for designing host-directed therapies for tuberculosis
A wealth of scientific and clinical evidence during the past few years has lent credence to the idea that key components of the host immune effector mechanisms can be targeted to boost current tuberculosis (TB) treatment and control patient relapse. These host‐directed strategies not only accelerate...
Main Authors: | , , |
---|---|
Other Authors: | |
Format: | Journal Article |
Language: | English |
Published: |
2019
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/89906 http://hdl.handle.net/10220/47778 |